PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Ian T. Meredith1*, MBBS, PhD; Robert Whitbourn2, MBBS; Douglas Scott3, MBChB; Seif El-Jack4, MD; Robaayah Zambahari5, MD; Gregg W. Stone6, MD; Paul S. Teirstein7, MD; Ruth M. Starzyk8, PhD; Dominic J. Allocco8, MD; Keith D. Dawkins8, MD
1. MonashHEART, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; 2. St. Vincent’s Hospital, Fitzroy, Victoria, Australia; 3. Middlemore Hospital, Centre for Clinical Research and Effective Practice, Otahuh
Aims: Assess clinical, angiographic, and intravascular ultrasound results in lesions treated with the PROMUS Element platinum chromium everolimus-eluting stent (EES).